Skip to search formSkip to main contentSkip to account menu

MCI 9042

Known as: MCI-9042 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
  • S. Doggrell
  • Expert opinion on investigational drugs
  • 2003
  • Corpus ID: 44640060
The main peripheral sources of 5-hydroxytryptamine (5-HT) are as a neurotransmitter and local hormone in the gastrointestinal… 
2001
2001
Serotonin (5-hydroxytryptamine, or 5-HT), released from activated platelets, not only accelerates aggregation of platelets but… 
Highly Cited
1999
Highly Cited
1999
Antiproliferative behavior of sarpogrelate (Anplag, MCI-9042, (+/-)-1-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)-2… 
1997
1997
Highly Cited
1995
Highly Cited
1995
  • H. Pertz, S. Elz
  • The Journal of pharmacy and pharmacology
  • 1995
  • Corpus ID: 25311518
The new antiplatelet agent sarpogrelate (MCI‐9042), its major metabolite (R,S)‐1‐[2‐[2‐(3‐methoxyphe‐nyl)ethyl]phenoxy]‐3… 
1992
1992
We investigated the effect of a new antiplatelet agent, MCI-9042 «±)-2-(dimethyl­ amino )-1-[[ o-(m-methoxyphenethyl)phenoxy… 
Highly Cited
1991
Highly Cited
1991
MCI-9042, (+/-)-1-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-3- (dimethylamino)-2-propyl hydrogen succinate hydrochloride inhibited… 
Highly Cited
1991
Highly Cited
1991
The antithrombotic effect of MCI-9042, (+-)-2-(dimethyl-amino)-1-((o-(m- methoxyphenethyl)phenoxyl]methyl]ethyl hydrogen… 
1991
1991
This study assessed the specificity of displacement potencies of MCI-9042 [+/-)-1-[o-[2-(m-methoxyphenyl)ethyl]phenoxy]-3…